BIOMAT Database Logo BIOMAT Database Logo

Clinical and genetic aspects of antithrombin III deficiency. 1983

F Halal, and G Quenneville, and S Laurin, and G Loulou

UI MeSH Term Description Entries
D007192 Indenes A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D005260 Female Females
D005799 Genes, Dominant Genes that influence the PHENOTYPE both in the homozygous and the heterozygous state. Conditions, Dominant Genetic,Dominant Genetic Conditions,Genetic Conditions, Dominant,Condition, Dominant Genetic,Dominant Gene,Dominant Genes,Dominant Genetic Condition,Gene, Dominant,Genetic Condition, Dominant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

F Halal, and G Quenneville, and S Laurin, and G Loulou
[Clinical and genetic aspects of antithrombin III deficiency and abnormal antithrombin III].
May 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology,
F Halal, and G Quenneville, and S Laurin, and G Loulou
Antithrombin III deficiency: clinical aspects.
January 1984, Haematologia,
F Halal, and G Quenneville, and S Laurin, and G Loulou
Clinical aspects of antithrombin III deficiency.
January 1991, Seminars in hematology,
F Halal, and G Quenneville, and S Laurin, and G Loulou
[Clinical aspects of acquired antithrombin III deficiency].
February 1986, Behring Institute Mitteilungen,
F Halal, and G Quenneville, and S Laurin, and G Loulou
Hereditary antithrombin III deficiency: biochemical aspects.
January 1984, Haematologia,
F Halal, and G Quenneville, and S Laurin, and G Loulou
[Antithrombin III (clinical aspects and methodology)].
January 1978, La Ricerca in clinica e in laboratorio,
F Halal, and G Quenneville, and S Laurin, and G Loulou
The clinical significance of antithrombin III deficiency.
November 1982, The Journal of the Oklahoma State Medical Association,
F Halal, and G Quenneville, and S Laurin, and G Loulou
Antithrombin III microheterogeneity in antithrombin III deficiency and in the antithrombin III abnormality, "antithrombin III Toyama".
July 1987, Thrombosis research,
F Halal, and G Quenneville, and S Laurin, and G Loulou
Antithrombin III deficiency.
December 1988, Blood reviews,
F Halal, and G Quenneville, and S Laurin, and G Loulou
Antithrombin III deficiency.
January 2003, Annals of cardiac anaesthesia,
Copied contents to your clipboard!